Akero Therapeutics, Inc. Operating Lease, Expense
Akero Therapeutics, Inc. reported Operating Lease, Expense of $305.00 thousand for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-16.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseExpense · last filed 2020-03-16
- Akero Therapeutics, Inc. operating lease, expense for fiscal 2019 was $305.00K.
| Period end | Operating Lease, Expense 12 month |
|---|---|
| 2019-12-31 | $305.00K 10-K · filed 2020-03-16 |